Articles Posted in Mass Torts

This page is about Truvada lawsuits and other HIV drug injury lawsuits involving kidney or bone injuries.

HIV drugs containing tenofovir disoproxil fumarate (TDF) are, we believe, putting patients at risk. This has resulted in HIV drug lawsuits from victims alleging kidney disease and failure, bone density loss, bone injuries, and other side effects.

Viread® and Truvada® are two of the first brand-name drugs developed by Gilead Sciences to treat HIV. Viread and Truvada both use tenofovir disoproxil fumarate (TDF), a new type of antiviral drug that was one of the first effective treatments for slowing HIV.

Thousands of women who underwent internal bra breast surgery are now experiencing serious complications from the surgical mesh placed inside them, and many are pursuing legal action against the manufacturers that promoted these products for a use the FDA never approved.

Breast mesh lawsuits allege that manufacturers of products such as AlloDerm, GalaFLEX, Phasix, and AlloMax marketed their devices for breast reconstruction, augmentation, and revision surgeries even though those applications had never been adequately studied or approved by the FDA. Patients were not warned. Surgeons were not given enough information. So when complications developed, including infection, mesh failure, chronic pain, and the need for additional surgery, most women did not have the information to connect the dots from their problems to the problems with the devices.

This page explains the internal bra mesh lawsuit in plain English: what the legal claims are, who may be eligible, what complications may qualify, and what these cases may be worth.

Dupixent (dupilumab) is a biologic medication used to treat atopic dermatitis, asthma, and other inflammatory conditions. It works by targeting specific immune pathways involved in allergic inflammation. For many patients with moderate to severe eczema, Dupixent has provided relief where topical medications failed. As a result, it has become one of the most widely prescribed biologic drugs for skin and respiratory conditions.

But for a growing number of patients, the experience with Dupixent has been very different. Over the past several years, doctors and researchers have reported cases in which patients treated with Dupixent were later diagnosed with cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma that primarily affects the skin. These reports have led to increasing scrutiny of whether Dupixent can worsen, accelerate, or mask CTCL in certain patients.

In many cases our lawyers are now investigating, patients who received Dupixent for newly diagnosed eczema and developed concerning symptoms within weeks or months, including swollen lymph nodes and worsening skin disease.

Our attorneys also provide the latest updates on the Zantac class action lawsuit (including the disastrous news that the class action judge dismissed all federal court Zantac lawsuits). This page was updated on April 21, 2026.

Zantac Cancer Lawsuit Updates 2026

The Zantac litigation has been a rollercoaster, filled with major victories, setbacks, and unexpected twists. From the initial discovery of NDMA contamination to the collapse of certain cases and the resurgence of others, this litigation has taken many turns.

Between 2013 and 2024, contaminated Olympus duodenoscopes infected hundreds of patients at hospitals across the United States. At least 35 people died. The infections were caused by drug-resistant bacteria that no antibiotic could reliably kill. The patients had gone into the hospital for routine diagnostic procedures–gallstone evaluations, pancreatic biopsies, bile duct imaging–and came out with infections that would destroy their organs, land them in intensive care for months, or kill them outright.

The remarkable part is not that it happened. Medical devices fail. Infections occur. What makes the Olympus duodenoscope litigation extraordinary is that the company knew. Olympus knew its scopes could not be adequately cleaned. Olympus knew that bacteria were surviving the sterilization process and spreading from patient to patient. Olympus knew that people were dying. And for years, the company did almost nothing.

This page explains what went wrong, why it went wrong, and the legal options available to patients and families harmed by contaminated Olympus scopes. It is long. It is detailed. It is written for people who want to understand not just the claims being filed, but the science, the regulatory failures, and the corporate decisions that turned a solvable engineering problem into a public health catastrophe.

If you swallowed a wire bristle from a grill brush or found a metal fragment in your food after cleaning your grill, you are not imagining things or overreacting. A wire bristle from a grill cleaning brush can break off during normal use, stick to a burger or hot dog without anyone seeing it, and end up in your throat, stomach, or intestines. These injuries can range from sharp throat pain and trouble swallowing to bowel perforation requiring emergency surgery.

The danger is not new. The CDC warned about grill brush bristle injuries years ago, after reports of people suffering internal injuries from tiny metal bristles that detached from brushes and were swallowed with grilled food. What changed in 2026 is that federal regulators took major action. The U.S. Consumer Product Safety Commission announced large recalls involving Weber and Nexgrill metal wire bristle grill brushes because detached bristles can stick to grills or food and cause serious internal injuries that may require medical treatment or surgery.

Together, the Weber and Nexgrill recalls cover more than 13 million grill brushes. Weber recalled about 3.2 million brushes after reports of bristles detaching, including cases where consumers required medical treatment. Nexgrill recalled more than 10.2 million brushes after at least 68 reports or reviews involving detached bristles, including five reports of consumers swallowing metal bristles and needing medical treatment to remove them from the throat or digestive tract. If you or someone in your family was hurt after using one of these brushes, there may be a product liability claim against the manufacturer.

Ocaliva was supposed to protect your liver. Instead, for many, it destroyed it.

 Ocaliva was sold as a treatment for primary biliary cholangitis, a chronic disease that damages the bile ducts in the liver. It came to market with promise. It left the market under a cloud of serious liver injury, transplant, and death.

By late 2025, the FDA had withdrawn approval of Ocaliva after concluding the postmarketing evidence showed excess liver transplants and deaths, and did not verify the clinical benefit the company needed to prove. Intercept then pulled the drug from the United States market.

Prilosec and Nexium kidney damage class action lawsuits are still being filed around the country.

Thousands of Proton Pump Inhibitor lawsuits have been filed around the country by plaintiffs who allege that PPI drugs like Nexium and Prilosec caused them to develop permanent kidney damage, bone fractures, and interstitial nephritis. As of August 2023, there are nearly 13,000 Nexium and Prilosec kidney damage lawsuits pending in a class action MDL.  Settlement rumors in this litigation are swirling.

April 2026 Case Count

Nitrous oxide cartridges, often sold under names like Whip-Its, Galaxy Gas, and Baking Bad, are now at the center of a growing wave of lawsuits across the country. Our lawyers are handling claims against manufacturers, distributors, and retailers for serious nitrous oxide injuries.

What was marketed as a novelty or culinary product has become a common recreational inhalant, especially among young people. Repeated use is dangerous. It can cause neurological injury, psychiatric damage, spinal cord dysfunction, and in some cases, death. Nitrous oxide use is now showing up in medical records, emergency rooms, and court filings. This is a serious and escalating problem.

Lawsuits allege that companies failed to warn about known risks, marketed products in ways that encouraged abuse, and ignored clear signs of harm. Cases include personal injury and wrongful death claims, as well as proposed class actions arising from deceptive labeling and distribution practices. These claims could eventually be consolidated in a federal MDL for coordinated pretrial proceedings.

Contact Information